National Institute of Cancer
About National Institute of Cancer
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Fondazione Melanoma Onlus
2
Clinical Trials at National Institute of Cancer
During the past decade, National Institute of Cancer conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Sequential Combo Immuno and Target Therapy (SECOMBIT) Study
2016-11-14
2024-05-31
Active, not recruiting
251
"Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)"
2021-02-18
2025-02-01
Recruiting
35
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Cancer"
#1 collaborator was "Clinical Research Technology S.r.l." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at National Institute of Cancer
According to Clinical.Site data, the most researched conditions in "National Institute of Cancer" are
"Melanoma" (1 trials) and "Metastatic Melanoma" (1 trials). Many other conditions were trialed in "National Institute of Cancer" in a lesser frequency.
Clinical Trials Intervention Types at National Institute of Cancer
Most popular intervention types in "National Institute of Cancer" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ipilimumab" (1 trials), "LGX818" (1 trials), "MEK162" (1 trials), "Nivolumab" (1 trials) and "Trametinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Institute of Cancer
The vast majority of trials in "National Institute of Cancer" are
2 trials for "All" genders.
Clinical Trials Status at National Institute of Cancer
Currently, there are NaN active trials in "National Institute of Cancer".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in National Institute of Cancer,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Institute of Cancer, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of National Institute of Cancer
National Institute of Cancer has several departments that took part in Clinical trials: "Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale" - 4 trials
Departments List
Name
City
Trials